These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: CFTR modulators: transformative therapies for cystic fibrosis.
    Author: Dwight M, Marshall B.
    Journal: J Manag Care Spec Pharm; 2021 Feb; 27(2):281-284. PubMed ID: 33506726.
    Abstract:
    DISCLOSURES: No funding contributed to the writing of this commentary. Both authors are employed by the Cystic Fibrosis Foundation. The Cystic Fibrosis Foundation has entered into therapeutic development award agreements and licensing agreements to assist with the development of CFTR modulators that may result in intellectual property rights, royalties, and other forms of consideration provided to CFF. Some of these agreements are subject to confidentiality restrictions and, thus, CFF cannot comment on them.
    [Abstract] [Full Text] [Related] [New Search]